Documents

Conclusions and next steps – forward planning of the meetings MSP Advisory Group 20 March 2024

Launch of call for Stakeholder Co-chair MSP Advisory Group 20 March 2024

Mandate and Rules of Procedure of the MSP Advisory Group 20 March 2024

ACT EU workplan and key priorities MSP Advisory Group 20 March 2024

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 March 2024)

ACT EU clinical trials analytics workshop report

MSP Advisory Group Mandate and rules of procedure

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-29 February 2024)

Draft Agenda Inaugural meeting MSP Advisory Group 20 March 2024

ACT EU multi-stakeholder workshop on methodology guidance report

Summary Gap analysis of training curriculum for clinical trial assessors

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 January 2024)

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 December 2023)

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 November 2023)

Revised CTIS transparency rules, interim period & historical trials: quick guide for users

ACT EU priority areas for possible EU-level funding

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-31 October 2023)

ACT EU multi-annual workplan 2023-2026

Key performance indicators (KPIs) to monitor the European clinical trials environment (1-30 September 2023)